Cars.com
CARS
Lantheus
LNTH
Halozyme Therapeutics
HALO
DOMINOS PIZZA ENTERPRISES LIMITED UNSP ADR EACH REPR 0.5 ORD SHS
DMZPY
Collegium Pharmaceutical
COLL
US Stock MarketDetailed Quotes
TIL Instil Bio
- 20.1000
- +0.7800+4.04%
Close Feb 28 16:00 ET
- 20.1000
- 0.00000.00%
Post 20:01 ET
131.17MMarket Cap-1.74P/E (TTM)
20.3000High19.0600Low78.22KVolume19.0600Open19.3200Pre Close1.55MTurnover2.93%Turnover RatioLossP/E (Static)6.53MShares92.000052wk High0.74P/B53.67MFloat Cap9.620052wk Low--Dividend TTM2.67MShs Float589.8000Historical High--Div YieldTTM6.42%Amplitude6.0600Historical Low19.8650Avg Price1Lot Size
About Instil Bio Company
Instil Bio, Inc. is a clinical-stage biopharmaceutical company engaged in developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte therapies for the treatment of patients with cancer. The company was founded in August 2018 and is headquartered in Dallas, TX.
Company Profile
SymbolTIL
Company NameInstil Bio
Listing DateMar 19, 2021
Issue Price20.00
Founded2018
CEOMr. Bronson Crouch
MarketNASDAQ
Employees49
Fiscal Year Ends12-31
Address3963 Maple Avenue,Suite 350
CityDallas
ProvinceTexas
CountryUnited States of America
Zip Code75225
Phone1-972-499-3350
Websitehttp://www.instilbio.com
Company Executives
- Name
- Position
- Salary
- Bronson Crouch
- Chief Executive Officer and Chairman of the Board
- 1.58M
- Dr. Sandeep Laumas, M.D.
- Principal Accounting Officer, Chief Financial Officer and Chief Business Officer
- 922.92K
- Dr. Neil Gibson,PhD
- Lead Independent Director
- 82.65K
- R. Kent McGaughy, Jr
- Independent Director
- 66.15K
- George Matcham, PhD
- Independent Director
- 57.15K
- Dr. Gwendolyn K. Binder-Scholl, M.D.,PhD
- Independent Director
- 57.15K